Banque Cantonale Vaudoise Karyopharm Therapeutics Inc. Transaction History
Banque Cantonale Vaudoise
- $2.55 Billion
- Q1 2024
A detailed history of Banque Cantonale Vaudoise transactions in Karyopharm Therapeutics Inc. stock. As of the latest transaction made, Banque Cantonale Vaudoise holds 25,000 shares of KPTI stock, worth $20,000. This represents 0.0% of its overall portfolio holdings.
Number of Shares
25,000
Previous 25,000
-0.0%
Holding current value
$20,000
Previous $22,000
72.73%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding KPTI
# of Institutions
120Shares Held
72.4MCall Options Held
476KPut Options Held
175K-
Black Rock Inc. New York, NY9.45MShares$7.56 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.34MShares$6.67 Million0.0% of portfolio
-
Avidity Partners Management LP Dallas, TX8.3MShares$6.64 Million0.48% of portfolio
-
Palo Alto Investors LP Palo Alto, CA5.1MShares$4.08 Million0.9% of portfolio
-
Eversept Partners, LP New York, NY5.02MShares$4.01 Million0.57% of portfolio
About Karyopharm Therapeutics Inc.
- Ticker KPTI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 79,806,600
- Market Cap $63.8M
- Description
- Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases. The company discovers, develops, and commercializes novel and Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and in...